Laser photocoagulation treatment ofthe central retina is often complicated by an immediate side effect of visual impairment, caused by the unavoidable laser-induced destruction ofthe normal tissue lying adjacent to the lesion and not affected directly by the laser beam. Furthermore, accidental laser injuries are at present untreatable. A neuroprotective therapy for salvaging the normal tissue might enhance the benefit obtained from treatment and allow sale perifoveal photocoagulation. We have developed a rat model for studying the efficacy ofputative neuroprotective compounds in ameliorating laser-induced retinal damage. Four compounds were evaluated: the corticosteroid methyiprednisolone, the glutamate-receptor blocker MK-801, the anti-oxidant enzyme superoxide dismutase, and the calcium-overload antagonist flunarizine. The study was carried out in two steps: in the first, the histopathological development of retinal laser injuries was studied. Argon laser lesions were inflicted in the retinas of 18 pigmented rats. The animals were sacrificed after 3, 20 or 60 days and their retinal lesions were evaluated under the light microscope. The laser injury mainly involved the outer layers ofthe retina, where it destroyed significant numbers of photoreceptor cells. Over time, evidence oftwo major histopathological processes was observed: traction of adjacent normal retinal cells into the central area ofthe lesion forming an internal retinal bulging, and a retinal pigmented epithelial proliferative reaction associated with subretinal neovascularization and invasion ofthe retinal lesion site by phagocytes. The neuroprotective effects of each ofthe four compounds were verified in a second step ofthe study. For each drug tested, 12 rats were irradiated with argon laser inflictions: six ofthem received the tested agent while the other six were treated with the corresponding vehicle. Twenty days after laser exposure, the rats were sacrificed and their lesions were subjected to image-analysis morphometiy. The extent ofretinal destruction was assessed by measuring the lesion diameter and the amount ofphotoreceptor cell loss in the outer nuclear layer. Methyiprednisolone and MK8O1 were shown to ameliorate laser-induced retinal damage, whereas both superoxide dismutase and flunarizine were ineffective. Furthermore, MK-801 diminished the proliferative reaction ofthe retinal pigment epithelial cells. On the basis of our results we suggest that the pigmented rat model is suitable for studying and screening various compounds for their neuroprotective efficacy in treating retinal laser injury. We further suggest that glutamate might play a key role in mediating retinal injury induced by laser irradiation.